BRAIDWELL LP Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001920938

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidHealth TiltHigh Turnover how tags are computed

Q1 2025 · 57 positions · Total reported value $2.29B · Top-10 concentration 42.3% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 75.0% · 24 new · 32 cut · 25 exited

Active Share (vs S&P 500): 98.9% · vs QQQ: 99.4% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q1 2026 → Q2 2026): +24.0% · vs SPY +9.2% · Prev Value $2.64B — last quarter positions weighted by this quarter price moves · ranking

In its Q1 2025 13F filing, BRAIDWELL LP disclosed 57 equity positions with a combined reported value of $2.29B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 42.3% of reported value. HoldingsHub classifies the profile as Mid / Health Tilt / High Turnover.

The largest disclosed positions as of Q1 2025 were NVCR ($136.61M), NBIX ($131.83M), LEGN ($101.04M). By sector, the heaviest allocations are Health Care 80.6%, Industrials 5.5%. Versus the prior quarter, allocation shifted toward Technology (+3.9pp), Industrials (+2.9pp) and away from Other (-3.0pp), Health Care (-3.8pp).

Versus the prior quarter, BRAIDWELL LP opened 24 new positions, trimmed 32 and fully exited 25, a turnover rate of 75.0% of positions. The portfolio's overlap with the prior quarter was 61% of names.

The largest new positions opened in Q1 2025 were TTMI ($89.74M), DHR ($63.41M), BPMC ($38.94M).

Of the 25 positions fully exited versus the prior quarter, the largest were AVDL ($43.15M), FNA ($39.61M), BNTX ($35.31M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q1 2025)

  • TTMI TTM TECHNOLOGIES INC · $89.74M
  • DHR DANAHER CORP DEL · $63.41M
  • BPMC BLUEPRINT MEDICINES CORP · $38.94M
  • ADPT ADAPTIVE BIOTECHNOLOGIES COR · $35.69M
  • ASND ASCENDIS PHARMA A/S · $16.63M
  • MDGL MADRIGAL PHARMACEUTICALS INC · $16.13M
  • CSTL CASTLE BIOSCIENCES INC COM · $7.31M
  • MTSR METSERA INC · $4.76M

Fully Exited (vs previous quarter)

  • AVDL AVADEL PHARMACEUTICALS PLC · prev qtr: $43.15M
  • FNA PARAGON 28 INC · prev qtr: $39.61M
  • BNTX BIONTECH SE · prev qtr: $35.31M
  • KROS KEROS THERAPEUTICS INC · prev qtr: $29.99M
  • IMTX IMMATICS N.V · prev qtr: $24.91M
  • GERN GERON CORP · prev qtr: $24.80M
  • BRKR BRUKER CORP · prev qtr: $20.70M
  • EXAS EXACT SCIENCES CORP · prev qtr: $19.84M

Insider Transactions (Form 4)

Latest BRAIDWELL LP buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Braidwell LP, based in Stamford, CT, United States, files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 83 positions worth $2.54B in total. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: STAMFORD, CT, United States
  • SEC registration: 801-122966 (status: Approved), registered 2022-01-03
  • Regulatory AUM (Form ADV): $3.63B as of 2026-09-22
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 12 private funds, of which 11 hedge funds
  • Website: braidwell.com

Portfolio Structure

  • 83 positions · $2.54B reported value (Q2 2026)
  • Top 10 holdings = 32.8% of reported value
  • Largest position: CAI (CARIS LIFE SCIENCES INC) at 5.8%
  • Average position size: $30.62M

Sector Tilt

  • Health Care 90.1%
  • Information Technology 4.3%
  • Industrials 4.3%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q2 2026: 24 new, 21 added, 32 reduced, 25 exited
  • 6 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 80.6%
Technology 3.9%
Other 10.0%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 140.83M $136.61M 5.95%
5.95%
Hold
2 1.19M $131.83M 5.75%
5.75%
Add
3 2.98M $101.04M 4.40%
4.40%
Hold
4 160.85K $95.20M 4.15%
4.15%
Add
5 2.71M $90.92M 3.96%
3.96%
Reduce
6 86.00M $89.74M 3.91%
3.91%
New
7 101.38M $87.95M 3.83%
3.83%
Reduce
8 530.53K $84.28M 3.67%
3.67%
Add
9 3.28M $80.41M 3.50%
3.50%
Hold
10 400.74K $72.25M 3.15%
3.15%
Add
11 127.73K $63.56M 2.77%
2.77%
Add
12 309.34K $63.41M 2.76%
2.76%
New
13 624.43K $61.46M 2.68%
2.68%
Add
14 840.95K $59.64M 2.60%
2.60%
Add
15 556.39K $58.24M 2.54%
2.54%
Reduce
16 1.54M $57.55M 2.51%
2.51%
Hold
17 854.88K $57.52M 2.51%
2.51%
Reduce
18 1.33M $56.54M 2.46%
2.46%
Reduce
19 2.46M $54.09M 2.36%
2.36%
Add
20 302.41K $48.17M 2.10%
2.10%
Add
21 48.59M $43.81M 1.91%
1.91%
Reduce
22 1.96M $43.60M 1.90%
1.90%
Reduce
23 88.00K $43.58M 1.90%
1.90%
Add
24 4.26M $43.19M 1.88%
1.88%
Hold
25 2.58M $41.60M 1.81%
1.81%
Hold
26 439.97K $38.94M 1.70%
1.70%
New
27 3.62M $37.88M 1.65%
1.65%
Add
28 1.65M $36.14M 1.57%
1.57%
Reduce
29 4.80M $35.69M 1.55%
1.55%
New
30 1.44M $34.68M 1.51%
1.51%
Reduce
31 110.13K $29.45M 1.28%
1.28%
Reduce
32 2.16M $28.18M 1.23%
1.23%
Add
33 3.54M $28.05M 1.22%
1.22%
Reduce
34 1.11M $27.28M 1.19%
1.19%
Hold
35 956.84K $25.45M 1.11%
1.11%
Add
36 8.35M $18.46M 0.81%
0.81%
Hold
37 18.50M $18.04M 0.79%
0.79%
Hold
38 1.66M $17.62M 0.77%
0.77%
Add
39 106.71K $16.63M 0.72%
0.72%
New
40 1.57M $16.13M 0.70%
0.70%
Add
41 48.69K $16.13M 0.70%
0.70%
New
42 234.50K $14.97M 0.65%
0.65%
Reduce
43 1.46M $14.25M 0.62%
0.62%
Reduce
44 81.66K $10.39M 0.45%
0.45%
Reduce
45 6.62M $9.74M 0.42%
0.42%
Add
46 884.31K $8.94M 0.39%
0.39%
Hold
47 980.77K $7.42M 0.32%
0.32%
Reduce
48 365.25K $7.31M 0.32%
0.32%
New
49 375.36K $6.81M 0.30%
0.30%
Reduce
50 752.54K $5.06M 0.22%
0.22%
Hold

FAQ

What did BRAIDWELL LP buy in 2025-Q1?

In its 2025-Q1 13F filing, BRAIDWELL LP reported 57 equity positions worth $2.29B in aggregate; its largest disclosed positions were NVCR ($136.61M), NBIX ($131.83M), LEGN ($101.04M).

How large is BRAIDWELL LP's portfolio?

BRAIDWELL LP reported $2.29B of long equity holdings across 57 positions as of 2025-Q1. Top-10 holdings account for 42.3% of reported value.

What is BRAIDWELL LP's investment style?

HoldingsHub classifies the portfolio as Mid / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/braidwell/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →